drugset / Trial / NCT00814268

COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke

NCT00814268 ↗

Phase 4 Completed 358 enrolled Sanofi Bristol-Myers Squibb · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Primary objective: * Comparison of efficacy of the combination therapy (clopidogrel plus aspirin) and the aspirin alone (main comparison) to prevent any recurrent ischemic lesion . Secondary objectives: * Comparison of Modified Rankin scale (mRS) scores; * Comparison of the Incidence of all kinds of stroke and vascular death; * Comparison of the Incidence of bleeding episodes (major and minor) and symptomatic intracerebral hemorrhages during the follow-up period.

Timeline

Start
2008-12
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg Oral
Subject Clopidogrel Small molecule 75 mg Oral

Indications